Eloxx Pharmaceuticals, Inc. Common Stock (ELOX)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) is listed on Nasdaq, where it has traded since December 11, 1998.
- Listed On
- Nasdaq
- Listed Since
- December 11, 1998
- Employees
- 7
- Market Cap
- $52M
About Eloxx Pharmaceuticals, Inc. Common Stock
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 20 institutions reported holding ELOX, with 2.5 million shares worth $34.7 million in aggregate. The largest reported holder was Nantahala Capital Management, with 400,000 shares worth $5.6 million. Of the 5 largest holders listed below, all 5 opened new positions in ELOX during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Nantahala Capital Management | 400,000 | $6M | New position |
| Samsara Biocapital | 400,000 | $6M | New position |
| Aberdeen Group | 400,000 | $6M | New position |
| Ecor1 Capital | 400,000 | $6M | New position |
| Siren, | 400,000 | $6M | New position |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is ELOX?
Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) is listed on Nasdaq, where it has traded since December 11, 1998.
Who are the largest institutional holders of ELOX?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of ELOX were Nantahala Capital Management, Samsara Biocapital and Aberdeen Group.
How many institutions own ELOX?
20 institutions reported a position in ELOX for the quarter ended June 30, 2026, worth $34.7 million in total.
Did institutions buy or sell ELOX last quarter?
Of the 5 largest reported holders, all 5 opened new positions in ELOX during the quarter. Every reported holder and its change is on the SentiSense ownership page for ELOX.
Every reported institutional holder, plus insider and congressional trades in ELOX, on SentiSense.